What is Dulcolax Laxative used for?

Use for relief of occasional constipation and irregularity this product generally produces bowel movement in 15 minutes to 1 hour

What pharmaceutical form is Dulcolax Laxative available in?

Dulcolax Laxative: Czopki 10 mg

What are the side effects of Dulcolax Laxative?

The most commonly reported adverse reactions during treatment are abdominal pain and diarrhoea. Adverse events have been ranked under headings of frequency using the following convention: Very common (≥ 1/10); common (≥ 1/100, < 1/10); uncommon (≥ 1/1000, <1/100); rare (≥ 1/10000, <1/1000); very rare (<1/10000). Immune system disorders Rare: anaphylactic reactions, angioedema, hypersensitivity. Metabolism and nutrition disorders Rare: dehydration. Nervous system disorders Uncommon: dizziness. Ra

Who should NOT take Dulcolax Laxative?

Bisacodyl Laxative Tablets are contraindicated in patients with ileus, intestinal obstruction, acute abdominal conditions including appendicitis, acute inflammatory bowel diseases, and severe abdominal pain associated with nausea and vomiting which may be indicative of the aforementioned severe conditions. Bisacodyl Laxative Tablets are also contraindicated in severe dehydration and in patients with Known hypersensitivity to bisacodyl or any other component of the product. In c

Does Dulcolax Laxative interact with other medications?

The concomitant use of antacids and milk products may reduce the resistance of the coating of the tablets and result in dyspepsia and gastric irritation. The concomitant use of diuretics or adreno-corticosteroids may increase the risk of electrolyte imbalance if excessive doses of Bisacodyl are taken. Electrolyte imbalance may lead to increased sensitivity to cardiac glycosides. The concomitant use of other laxatives may enhance the gastrointestinal side effects of Bisacodyl.

Can Dulcolax Laxative be used during pregnancy?

Fertility No studies on the effect on human fertility have been conducted. Pregnancy There are no adequate and well-controlled studies in pregnant women. Long experience has shown no evidence of undesirable or damaging effects during pregnancy. Lactation Clinical data show that neither the active moiety of bisacodyl (BHPM or bis-(p-hydroxyphenyl)-pyridyl-2-methane) nor its glucuronides are excreted into the milk of healthy lactating females. Nevertheless, as with all medicines,

What precautions should be taken with Dulcolax Laxative?

Warnings For rectal use only Ask a doctor before use if you have stomach pain, nausea or vomiting noticed a sudden change in bowel habits that lasts more than 2 weeks When using this product it may cause stomach discomfort, faintness, rectal burning and mild cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition. you need to use a laxative for more than 1 week If pregnan

How should Dulcolax Laxative be stored?

Other information store at controlled room temperature 20°-25°C (68°-77°F); excursions permitted between 15º-30ºC (59º-86ºF) avoid excessive humidity package not child resistant

What ATC class does Dulcolax Laxative belong to?

Dulcolax Laxative: ATC A06AB02. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

Dulcolax Laxative

This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.

ATC code: A06AB02 Bisacodyl is a locally acting laxative from the diphenylmethane derivatives group having a dual action.‍‍‍‍‍‍‍‍ As a contact laxative, for which also antiresorptive hydragogue effects have been described, bisacodyl stimulates after hydrolysis in the large intestine, the mucosa of both the large intestine and of the rectum. Stimulation of the mucosa of the large intestine results in colonic peristalsis with promotion of accumulation of water, and consequently electrolytes, in the colonic lumen. This results in a stimulation of defecation, reduction of transit time and softening of the stool. Bisacodyl showed improvements in constipation-related symptoms like straining, stool consistency, abdominal discomfort and bloating compared with placebo, based on patient self-assessment questionary. Normalization of evacuatory function by bisacodyl treatment was accompanied by a relative normalization of the microflora. The results of two-phase IV clinical trials with a total of 29 patients treated by low dose (5 mg) of bisacodyl indicate that the transit through the colon, assessed through MRI, is promoted by stimulating propulsive colon motor activity with bisacodyl. In addition, repeated doses of bisacodyl 5mg during three consecutive days showed an increase in the water content in the gut. These trials demonstrated that there was no change in the underlying physiology which showed to return to baseline values 24 hours after ceasing treatment with bisacodyl. Stimulation of the rectum causes increased motility and a feeling of rectal fullness. The rectal effect may help to restore the “call to stool” although its clinical relevance remains to be established. As a laxative that acts on the colon, bisacodyl specifically stimulates the physiological natural evacuation process in the lower region of the gastrointestinal tract. Because its main effect is on the distal part of the gut, bisacodyl is ineffective in altering the digestion or absorption of calories or essential nutrients in the small intestine.

Dulcolax Laxative

User Reviews